Euroapi Company Description

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.

It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids.

The company was incorporated in 2020 and is based in Paris, France.

Euroapi S.A.

Country	France
Founded	2020
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	3,329
CEO	Ludwig De Mot

Contact Details

Address: 15 Rue Traversiere Paris, 75012 France
Phone	33 1 89 20 62 00
Website	euroapi.com

Stock Details

Ticker Symbol	EAPI
Exchange	Euronext Paris
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	FR0014008VX5
SIC Code	2833

Key Executives

Name	Position
Ludwig De Mot	Chief Executive Officer, Executive Vice President and Chief Transformation Officer
Olivier Falut	Chief Financial Officer
David Seignolle	Chief Operating Officer
Kai Rossen	Chief Scientific Officer
Sophie Palliez	Head of Investor Relations
Marion Santin	Chief Legal, Compliance, and IP Officer
Ute Herzog	Chief Human Resources Officer
Cecile Maupas	Chief CDMO (Contract Development and Manufacturing Organization) Officer
Vincent Touraille	Chief Strategy and M&A Officer
Bruno Laforge	Chief Corporate Affairs Officer